356 related articles for article (PubMed ID: 33199898)
1. Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life.
Uhlmann RE; Rother C; Rasmussen J; Schelle J; Bergmann C; Ullrich Gavilanes EM; Fritschi SK; Buehler A; Baumann F; Skodras A; Al-Shaana R; Beschorner N; Ye L; Kaeser SA; Obermüller U; Christensen S; Kartberg F; Stavenhagen JB; Rahfeld JU; Cynis H; Qian F; Weinreb PH; Bussiere T; Walker LC; Staufenbiel M; Jucker M
Nat Neurosci; 2020 Dec; 23(12):1580-1588. PubMed ID: 33199898
[TBL] [Abstract][Full Text] [Related]
2. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Sevigny J; Chiao P; Bussière T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; O'Gorman J; Qian F; Arastu M; Li M; Chollate S; Brennan MS; Quintero-Monzon O; Scannevin RH; Arnold HM; Engber T; Rhodes K; Ferrero J; Hang Y; Mikulskis A; Grimm J; Hock C; Nitsch RM; Sandrock A
Nature; 2016 Sep; 537(7618):50-6. PubMed ID: 27582220
[TBL] [Abstract][Full Text] [Related]
3. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
[TBL] [Abstract][Full Text] [Related]
4. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
5. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
6. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
7. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
8. Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
Bastrup J; Hansen KH; Poulsen TBG; Kastaniegaard K; Asuni AA; Christensen S; Belling D; Helboe L; Stensballe A; Volbracht C
J Alzheimers Dis; 2021; 79(1):249-265. PubMed ID: 33252074
[TBL] [Abstract][Full Text] [Related]
9. Highly potent intracellular membrane-associated Aβ seeds.
Marzesco AM; Flötenmeyer M; Bühler A; Obermüller U; Staufenbiel M; Jucker M; Baumann F
Sci Rep; 2016 Jun; 6():28125. PubMed ID: 27311744
[TBL] [Abstract][Full Text] [Related]
10. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
[TBL] [Abstract][Full Text] [Related]
12. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
13. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
[TBL] [Abstract][Full Text] [Related]
15. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
[TBL] [Abstract][Full Text] [Related]
16. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice.
Balakrishnan K; Rijal Upadhaya A; Steinmetz J; Reichwald J; Abramowski D; Fändrich M; Kumar S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2015 Jul; 3():41. PubMed ID: 26141728
[TBL] [Abstract][Full Text] [Related]
17. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
[TBL] [Abstract][Full Text] [Related]
19. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
[TBL] [Abstract][Full Text] [Related]
20. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
Novotny R; Langer F; Mahler J; Skodras A; Vlachos A; Wegenast-Braun BM; Kaeser SA; Neher JJ; Eisele YS; Pietrowski MJ; Nilsson KP; Deller T; Staufenbiel M; Heimrich B; Jucker M
J Neurosci; 2016 May; 36(18):5084-93. PubMed ID: 27147660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
